News | May 22, 2026
Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore
Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore
Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern
New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Access to genomic testing, not therapy cost, is the biggest challenge
The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care
The target reach is of more than 30 million young people and caregivers across 21 countries
The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
Subscribe To Our Newsletter & Stay Updated
